Not applicableStudy completedNCT01847287What this trial is testingA Longitudinal Study of Brain Atrophy in MS Patients Over 5 YearsWho this might be right forMultiple Sclerosis University at Buffalo 60
Early research (Phase 1)Study completedNCT00242177What this trial is testingPilot Test of ACTOS in Multiple Sclerosis: Safety and TolerabilityWho this might be right forMultiple Sclerosis, Relapsing-Remitting University of Illinois at Chicago 30
Testing effectiveness (Phase 2)Looking for participantsNCT07085507What this trial is testingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VT7208 in Healthy Participants and MS PatientsWho this might be right forMultiple Sclerosis Vidya Therapeutics Inc 100
Not applicableStudy completedNCT03458767What this trial is testingA Cognitive Self-Management Intervention for Persons With Multiple Sclerosis: Adapting Web-based TechnologyWho this might be right forMultiple Sclerosis University of Texas at Austin 16
Not applicableLooking for participantsNCT07475377What this trial is testingUnderstanding the Impact of Meal Timing on Neurological Health in Adults With Multiple SclerosisWho this might be right forMultiple Sclerosis University of Alabama at Birmingham 22
Not applicableStudy completedNCT01979081What this trial is testingDetecting and Addressing Preclinical DisabilityWho this might be right forBack PainCoronary Artery DiseaseChronic Obstructive Pulmonary Disease+7 more McMaster University 148
Testing effectiveness (Phase 2)UnknownNCT03005119What this trial is testingEvaluation of the Safety, Tolerability, and Efficacy of Orally Administered PTL201 in MS Patients With Spasticity-related SymptomsWho this might be right forMultiple Sclerosis PhytoTech Therapeutics, Ltd. 70
Early research (Phase 1)Ended earlyNCT05064436What this trial is testingEvaluate the Safety, Tolerability, Kinetics, Biodistribution and Repeatability of 11C-BMS-986196 After Intravenous (IV) Administration in Healthy Participants and After Repeat IV Administration in Participants With Multiple SclerosisWho this might be right forMultiple Sclerosis (MS) Bristol-Myers Squibb 10
Not applicableStudy completedNCT07789171What this trial is testingSynbiotic Supplementation as a Part of Dietary Modification in Multiple SclerosisWho this might be right forMultiple Sclerosis (MS) - Relapsing-remitting Hacettepe University 38
Post-approval studies (Phase 4)Study completedNCT03257358What this trial is testingImmune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg FingolimodWho this might be right forRelapsing Multiple Sclerosis Novartis Pharmaceuticals 382
Not applicableLooking for participantsNCT05355389What this trial is testingCognitive-motor Telerehabilitation in MSWho this might be right forMultiple Sclerosis Universitair Ziekenhuis Brussel 90
Not applicableWithdrawnNCT04925778What this trial is testingObservational Study in Patients With Relapsing-Remitting Multiple Sclerosis Switched to Bafiertam® From Dimethyl FumarateWho this might be right forRelapsing Remitting Multiple Sclerosis Banner Life Sciences LLC
Large-scale testing (Phase 3)Study completedNCT01167426What this trial is testingEvaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) PatientsWho this might be right forMultiple Sclerosis Teva Neuroscience, Inc. 148
Not applicableStudy completedNCT01125475What this trial is testingA Scandinavian Non-interventional Study of Adherence to RebiSmart Administered Rebif New Formulation (RNF) Treatment in Relapsing Remitting Multiple Sclerosis (RRMS) SubjectsWho this might be right forRelapsing Remitting Multiple Sclerosis (RRMS) Merck KGaA, Darmstadt, Germany 61
Large-scale testing (Phase 3)Study completedNCT05232825What this trial is testingA Phase III, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study To Investigate The Pharmacokinetics, Pharmacodynamics, Safety And Radiological And Clinical Effects Of Subcutaneous Ocrelizumab Versus Intravenous Ocrelizumab In Patients With Multiple SclerosisWho this might be right forRelapsing Multiple SclerosisPrimary Progressive Multiple Sclerosis Hoffmann-La Roche 236
Post-approval studies (Phase 4)Not Yet RecruitingNCT07240649What this trial is testingEmerging Indications for Hyperbaric Oxygen TreatmentWho this might be right forPost-COVID-19 ConditionUlcerative ColitisCrohn Disease+38 more Jay C. Buckey Jr. 100
Post-approval studies (Phase 4)UnknownNCT04550455What this trial is testingA Prospective Biomarker Study in Active SPMS Subjects Treated With Cladribine TabletsWho this might be right forMultiple Sclerosis Keith Edwards, M.D. 30
Not applicableLooking for participantsNCT06330350What this trial is testingQualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive CounsellingWho this might be right forQuality of LifeIchthyosisPalmoplantar Keratoses+7 more Maastricht University Medical Center 25
Not applicableStudy completedNCT05090033What this trial is testingCharacterizing the Use of Ofatumumab in a Real World SettingWho this might be right forRelapsing Multiple Sclerosis Novartis Pharmaceuticals 103
Early research (Phase 1)Study completedNCT00616733What this trial is testing12-week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis PatientsWho this might be right forMultiple Sclerosis Daiichi Sankyo 25